Erk5 and its potential applications in cancer treatment.

A new editorial paper published in Oncoscience discusses the role of Erk5, a protein belonging to the mitogen-activated protein kinase (MAPK) family, in cancer treatment. The researchers highlight that understanding the function of Erk5 in cancer will contribute to a better understanding of cancer pathogenesis and the development of novel therapeutic strategies. The paper also explores the role of Erk5 in bone homeostasis and its potential applications in cancer treatment. The researchers generated and analyzed conditional Erk5 knockout mice to investigate the function of Erk5 in bone marrow mesenchymal stem cells. [Extracted from the article]